We conducted a survey of the current status of pharmacotherapy for osteoporotic fracture patients at our hospital. The subjects were the 96 patients with osteoporotic fractures admitted to our hospital between June 2020 and May 2021 (proximal femoral fracture: 48 patients, N group; spinal compression fracture: 32 patients, C group; distal radius fracture: 16 patients, R group). The compliance rate was 40% in the N group, 75% in the C group, and 63% in the R group. Selection of the drug according to the patient's background at the start of treatment and patient and family guidance appeared to improve the osteoporotic treatment compliance rate.